Palladium-based nanomaterials for cancer imaging and therapy
In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials,...
Saved in:
Published in | Theranostics Vol. 10; no. 22; pp. 10057 - 10074 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Ivyspring International Publisher Pty Ltd
01.01.2020
Ivyspring International Publisher |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented. |
---|---|
AbstractList | In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented. In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented.In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical properties, excellent biocompatibility and high stability in physiological environment. Compared with other intensively studied noble nanomaterials, such as gold (Au) and silver (Ag) nanomaterials, research on Pd-based nanomaterials started late, but the distinctive features, such as high photothermal conversion efficiency and high photothermal stability, have made them getting great attention in the field of nanomedicine. The goal of this review is to provide a comprehensive and critical perspective on the recent progress of Pd-based nanomaterials as imaging contrast agents and therapeutic agents. The imaging section focuses on applications in photoacoustic (PA) imaging, single-photon emission computed tomography (SPECT) imaging, computed tomography (CT) imaging and magnetic resonance (MR) imaging. For treatment of cancer, single photothermal therapy (PTT) and PTT combined with other therapeutic modalities will be discussed. Finally, the safety concerns, forthcoming challenges and perspective of Pd-based nanomaterials on biomedical applications will be presented. |
Author | Li, Jingchao Liu, Yongchun Zheng, Nanfeng Chen, Xiaolan Chen, Mei |
AuthorAffiliation | 2 Department of Chemistry, Xiamen University, Xiamen, China 1 College of Materials Science and Engineering, Hunan University, Changsha, China |
AuthorAffiliation_xml | – name: 2 Department of Chemistry, Xiamen University, Xiamen, China – name: 1 College of Materials Science and Engineering, Hunan University, Changsha, China |
Author_xml | – sequence: 1 givenname: Yongchun surname: Liu fullname: Liu, Yongchun – sequence: 2 givenname: Jingchao surname: Li fullname: Li, Jingchao – sequence: 3 givenname: Mei surname: Chen fullname: Chen, Mei – sequence: 4 givenname: Xiaolan surname: Chen fullname: Chen, Xiaolan – sequence: 5 givenname: Nanfeng surname: Zheng fullname: Zheng, Nanfeng |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32929334$$D View this record in MEDLINE/PubMed |
BookMark | eNptkV9L5DAUxcOirDrrix9ACr4sQt0kvWkSEGER_4GwPrjPIU3TmUibjEkrzLc3o6OomJcE7u8czsndQ1s-eIvQAcEnnDD8Z1z4cAJMSvwD7RJRiZLXgLc-vHfQfkoPOB_AVBL5E-1UVFJZVbCLTu903-vWTUPZ6GTbwmsfBj3a6HSfii7EwmhvbCzcoOfOzwvt22Jc2KiXq19ou8uU3d_cM_T_8uL-_Lq8_Xd1c_73tjTA6VgC7VqoWwBN6pYZwqQ1uObEms4YQXBjgRoOwLBoMddSsyYrLM9qDqYh1Qydvfoup2awrbF-jLpXy5gzxZUK2qnPE-8Wah6eFAdBAIts8HtjEMPjZNOoBpeMzc29DVNSFIAKEDWrM3r0BX0IU_S5nqJMCgpMiHWiw4-J3qO8fWwGjl8BE0NK0XbvCMFqvTi1Xpx6WVyG8RfYuFGPLqzbuP47yTNBX5uk |
CitedBy_id | crossref_primary_10_3390_ijms241411442 crossref_primary_10_1007_s10876_024_02634_9 crossref_primary_10_1016_j_cclet_2021_12_057 crossref_primary_10_1021_acsanm_4c06257 crossref_primary_10_1021_acsomega_3c10324 crossref_primary_10_3390_catal13101343 crossref_primary_10_1007_s12649_024_02882_w crossref_primary_10_1002_adhm_202500260 crossref_primary_10_1016_j_addr_2022_114506 crossref_primary_10_2147_IJN_S444471 crossref_primary_10_1016_j_tice_2023_102087 crossref_primary_10_34133_2021_9816594 crossref_primary_10_3390_ijms252413555 crossref_primary_10_1186_s12943_023_01784_0 crossref_primary_10_1039_D2NA00897A crossref_primary_10_1016_j_bioadv_2025_214236 crossref_primary_10_1021_acsami_4c03530 crossref_primary_10_1039_D2SC00460G crossref_primary_10_34133_bmr_0158 crossref_primary_10_3390_jnt4020008 crossref_primary_10_1002_smll_202005499 crossref_primary_10_1016_j_mtchem_2020_100402 crossref_primary_10_1002_anbr_202300107 crossref_primary_10_1007_s10904_023_02657_1 crossref_primary_10_3390_ijms22168736 crossref_primary_10_3390_ijms25094733 crossref_primary_10_1002_bit_28472 crossref_primary_10_1002_smll_202201179 crossref_primary_10_1021_acs_jpclett_3c03205 crossref_primary_10_2174_0113894501283669240123105250 crossref_primary_10_3762_bjnano_14_33 crossref_primary_10_1016_j_carbpol_2021_119021 crossref_primary_10_1016_j_ijpharm_2022_121489 crossref_primary_10_3390_pharmaceutics16091162 crossref_primary_10_1016_j_eurpolymj_2024_112835 crossref_primary_10_1039_D2CE00662F crossref_primary_10_1039_D4BM00057A crossref_primary_10_1186_s12943_024_02161_1 crossref_primary_10_1016_j_mtchem_2021_100694 crossref_primary_10_3389_fonc_2022_939365 crossref_primary_10_3390_hydrogen2040025 crossref_primary_10_1016_j_jphotochem_2022_114510 crossref_primary_10_1039_D1MA00069A crossref_primary_10_1016_j_mri_2024_04_012 crossref_primary_10_1142_S1793292024300081 crossref_primary_10_1016_j_jinorgbio_2021_111429 crossref_primary_10_1002_slct_202103877 crossref_primary_10_1016_j_cej_2024_158682 crossref_primary_10_1186_s12951_023_02268_5 crossref_primary_10_1016_j_jece_2024_113523 crossref_primary_10_1016_j_cej_2022_136296 crossref_primary_10_1016_j_nantod_2021_101208 crossref_primary_10_1039_D0TB02138E crossref_primary_10_3390_ma15196521 crossref_primary_10_1016_j_jclepro_2023_136479 crossref_primary_10_1021_acsami_2c07281 crossref_primary_10_1186_s40164_024_00525_3 crossref_primary_10_1002_smll_202007179 crossref_primary_10_1002_adma_202202609 crossref_primary_10_1016_j_apsadv_2025_100713 crossref_primary_10_3389_fphar_2022_832725 crossref_primary_10_1016_j_aca_2024_343004 crossref_primary_10_1016_j_ceramint_2021_09_108 crossref_primary_10_26896_1028_6861_2023_89_12_5_12 crossref_primary_10_1016_j_ceramint_2022_06_178 crossref_primary_10_1021_acsabm_2c00759 crossref_primary_10_1021_acsabm_3c00458 crossref_primary_10_1016_j_trac_2024_117801 crossref_primary_10_1016_j_jconrel_2022_06_050 crossref_primary_10_1039_D1CS01148K crossref_primary_10_1039_D2TB01787C crossref_primary_10_1007_s10238_023_01262_3 crossref_primary_10_51435_turkjac_1203081 crossref_primary_10_1016_j_jmgm_2024_108928 crossref_primary_10_3390_biomedicines12071500 crossref_primary_10_3390_molecules26144369 crossref_primary_10_1002_asia_202300477 crossref_primary_10_1039_D2RA03860A |
ContentType | Journal Article |
Copyright | The author(s). 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The author(s) 2020 |
Copyright_xml | – notice: The author(s). – notice: 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The author(s) 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.7150/thno.45990 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic Proquest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1838-7640 |
EndPage | 10074 |
ExternalDocumentID | PMC7481408 32929334 10_7150_thno_45990 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- 53G 5VS 7X7 8FI 8FJ AAYXX ABUWG ADBBV ADRAZ AENEX AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR CCPQU CITATION DIK FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 M~E O5R O5S OK1 PGMZT PHGZM PHGZT PIMPY RPM UKHRP CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c472t-42fd46d44a16d5c159ec0671ecfcc810be42c744508d07a9a5b2fde7c4774cb13 |
IEDL.DBID | M48 |
ISSN | 1838-7640 |
IngestDate | Thu Aug 21 14:12:19 EDT 2025 Thu Jul 10 22:51:17 EDT 2025 Mon Jun 30 10:55:32 EDT 2025 Mon Jul 21 05:39:10 EDT 2025 Tue Jul 01 04:04:03 EDT 2025 Thu Apr 24 22:53:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Keywords | combined cancer therapy safety profile Palladium-based nanomaterials cancer imaging photothermal therapy |
Language | English |
License | The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c472t-42fd46d44a16d5c159ec0671ecfcc810be42c744508d07a9a5b2fde7c4774cb13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 These authors contributed equally to this work. Competing Interests: The authors have declared that no competing interest exists. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.7150/thno.45990 |
PMID | 32929334 |
PQID | 2598245881 |
PQPubID | 5263173 |
PageCount | 18 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7481408 proquest_miscellaneous_2442848656 proquest_journals_2598245881 pubmed_primary_32929334 crossref_primary_10_7150_thno_45990 crossref_citationtrail_10_7150_thno_45990 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-01-01 |
PublicationDateYYYYMMDD | 2020-01-01 |
PublicationDate_xml | – month: 01 year: 2020 text: 2020-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Australia |
PublicationPlace_xml | – name: Australia – name: Wyoming – name: Sydney |
PublicationTitle | Theranostics |
PublicationTitleAlternate | Theranostics |
PublicationYear | 2020 |
Publisher | Ivyspring International Publisher Pty Ltd Ivyspring International Publisher |
Publisher_xml | – name: Ivyspring International Publisher Pty Ltd – name: Ivyspring International Publisher |
SSID | ssj0000402919 |
Score | 2.5078247 |
SecondaryResourceType | review_article |
Snippet | In recent decade, palladium-based (Pd-based) nanomaterials have shown significant potential for biomedical applications because of their unique optical... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 10057 |
SubjectTerms | Animals Biocompatibility Cancer therapies Chemotherapy Contrast agents Contrast Media - administration & dosage Copyright Diagnostic Imaging - methods Efficiency Humans Lasers Morphology Nanomaterials Nanostructures - chemistry Neoplasms - diagnostic imaging Neoplasms - therapy Palladium Palladium - chemistry Phototherapy - methods Research Paper |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT9wwEB3xcWkPFeWjBGgVBBcOLok9iWMJCVVVEUKi6gGkvUWJ7RUrgUNh98C_ZybJhoVWnD1RopmJ3_PYfgNwWEhvFOGQ0GbsBKayEnWeO5FmVjHk1rnl0sDl7_z8Gi9G2agvuD32xyrnc2I7UbvGco38WLLSHF-rTE_v_wruGsW7q30LjWVYZekyzmo90kONhRJUmtR0qqSaqM_x9CY03zFrp-BFHPqHXL49I7kAOmdr8Klni_GPLryfYcmHdfi4oCG4ASd_uBTuJrM7wYjk4lCFhmhol1kxcdLYcmQf4sld25EoroKLu2tXT5twffbr6ue56FsiCItaTgXKscPcIVZp7jJLXMRbwpvU27G1RZrUHqXViES7XKIrU2U1PeE1Pa3R1qnagpXQBL8N8dho40yi6twl6ExWqMTmiuC-IE5BJC6Co7mDStvrhXPbituS1g3szJKdWbbOjOBgsL3vVDL-a7U393PZ_ymP5UtcI9gfhinHeeOiCr6ZkQ3SIgkLop4RfOnCMrxGSSJ4SmEE-lXABgPWz349EiY3rY62Rpb7Knbe_6xd-CB5jd2WXfZgZfow81-JiEzrb222PQPv2t8j priority: 102 providerName: ProQuest |
Title | Palladium-based nanomaterials for cancer imaging and therapy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32929334 https://www.proquest.com/docview/2598245881 https://www.proquest.com/docview/2442848656 https://pubmed.ncbi.nlm.nih.gov/PMC7481408 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjZ3fS8MwEMcPnS_6IP62OkdFX3zIbJtr0oIgKooIioiDvZU2yXCgmc4N9L_30nbDqQ8-90LLXZr7XNp8D-AwiUzKKQ8xmfY0wzDKWSGEZmGsuEu5hVBua-D2Tlx38KYbd-dg0r-zduD7n6Wd6yfVGT63P94-T-mFJ35tS-KZ49GTHbQxpnV1HhYoI0nXyeC2xvxyRaYiKS17fNAETpgUGFRKpT-Gz-amX8D587_Jb4noagWWa4L0z6qQr8KcsWuw9E1XcB1O7t32uO6PX5jLUtq3uR0QmlazzSdO9ZWL9tDvv5Rdivzcar86ivW5AZ2ry8eLa1a3SWAKZTRiGPU0Co2Yh0LHivjEKMpBoVE9pZIwKAxGSiISiulA5mkeFzTCSBotURUh34SGHVizDX4vlalOA14IHaBO44QHSnBCgIQ4g8DOg6OJgzJVa4i7VhbPGdUSzpmZc2ZWOtODg6nta6Wc8adVc-LnbBL8LHKqgu4IbejB_vQyzXv3MSO3ZjAmG6TCCRPCUQ-2qrBMb8Mjgj7O0QM5E7CpgdPUnr1i-0-ltrZEJwGW7Pzr4XdhMXLld7kj04TGaDg2e8Qoo6IF87IrW7Bwfnl3_9Aqp-MXaf_oPg |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V9gAcEOUZKMUIOHAwTWwnjiUQqlqqLX2IQyvtLU1sr7pS6_SxK9Q_1d_YmWQTtoC49ZxxEo3HM9-M7W8APuTCG4lxiGszclwlouRVljmepFZSyK0yS6WBvf1scKh-DNPhAlx3d2HoWGXnExtH7WpLNfI1QUxzdK0y-XZ2zqlrFO2udi00WrPY8Ve_MGW7_Lq9ifP7UYit7wcbAz7rKsCt0mLClRg5lTmlyiRzqcVw7i267MTbkbV5EldeCauVQuTiYl2aMq1whNc4WitbJRLfew-WMPDGlOzpoe5rOrgghElMy4KqEWqtTY5D_Vmljcufj3t_gdk_z2TOBbmtx_Bohk7ZemtOy7DgwxN4OMdZ-BS-_KTSuxtPTzlFQMdCGWqEva0lM8TAzJIlXbDxadMBiZXBsfaa19UzOLwTZT2HxVAH_xLYyGjjTCyrzMXKmTSXsc0kwoscVYmgMYJPnYIKO-MnpzYZJwXmKaTMgpRZNMqM4H0ve9aycvxTaqXTczFbmZfFbzuK4F3_GNcUbZSUwddTlFGYlKkcoW4EL9pp6T8jBQJKKVUE-taE9QLE1337SRgfN7zdWhG9WP7q_7_1Fu4PDvZ2i93t_Z3X8EBQft-UfFZgcXIx9W8QBE2q1cbyGBzdtanfALqvHIE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VrYToAfFNoIARcOBgNrGdOJZACGhXLYXVClGpt5DYjrpSm5R2V6h_jV_HTL7YAuLWc-wkGj973oztNwDPU-GNRD_EtSkdV5HIeZEkjkexleRyi8RSauDzNNnZVx8P4oM1-NnfhaFjlf2a2CzUrraUIx8LUpqja5XRuOyORcy2Jm9PvnOqIEU7rX05jRYie_78B4ZvZ292t3CsXwgx2f76YYd3FQa4VVosuBKlU4lTKo8SF1t07d7i8h15W1qbRmHhlbBaKWQxLtS5yeMCe3iNvbWyRSTxvVdgXVNUNIL199vT2Zchw4PTQ5jItJqoGonXeHFY1a9U3DiAVS_4F7X984Tmisub3IDrHVdl71pw3YQ1X92CjRUFw9vwekaJeDdfHnPyh45VeVUjCW5xzZARM0u4OmXz46YeEssrx9pLX-d3YP9SzHUXRlVd-fvASqONM6EsEhcqZ-JUhjaRSDZSZDRIIQN42Rsos51aORXNOMowaiFjZmTMrDFmAM-GtietRsc_W232ds66eXqW_UZVAE-HxzjDaNskr3y9xDYKQzSVIvEN4F47LMNnpEB6KaUKQF8YsKEBqXdffFLNDxsVb61IbCx98P_fegJXEebZp93p3kO4JijYb_I_mzBanC79I2REi-JxBz0G3y4b7b8AgmQiHA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Palladium-based+nanomaterials+for+cancer+imaging+and+therapy&rft.jtitle=Theranostics&rft.au=Liu%2C+Yongchun&rft.au=Li%2C+Jingchao&rft.au=Chen%2C+Mei&rft.au=Chen%2C+Xiaolan&rft.date=2020-01-01&rft.issn=1838-7640&rft.eissn=1838-7640&rft.volume=10&rft.issue=22&rft.spage=10057&rft.epage=10074&rft_id=info:doi/10.7150%2Fthno.45990&rft.externalDBID=n%2Fa&rft.externalDocID=10_7150_thno_45990 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1838-7640&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1838-7640&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1838-7640&client=summon |